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Abstract
Background: We set out to estimate net survival trends for 10 common cancers in 279 cancer registry populations in
67 countries around the world, as part of the CONCORD-2 study. Net survival can be interpreted as the proportion of
cancer patients who survive up to a given time, after eliminating the impact of mortality from other causes
(background mortality). Background mortality varies widely between populations and over time. It was
therefore necessary to construct robust life tables that accurately reflected the background mortality in each
of the registry populations.
Methods: Life tables of all-cause mortality rates by single year of age and sex were constructed by calendar
year for each population and, when possible, by racial or ethnic sub-groups. We used three different
approaches, based on the type of mortality data available from each registry. With death and population
counts, we adopted a flexible multivariable modelling approach. With unsmoothed mortality rates, we used
the Ewbank relational method. Where no data were available from the registry or a national statistical office,
we used the abridged UN Population Division life tables and interpolated these using the Elandt-Johnson
method. We also investigated the impact of using state- and race-specific life tables versus national race-
specific life tables on estimates of net survival from four adult cancers in the United States (US).
Results: We constructed 6,514 life tables covering 327 populations. Wide variations in life expectancy at birth and
mortality by age were observed, even within countries. During 1995–99, life expectancy was lowest in Nigeria and
highest in Japan, ranging from 47 to 84 years among females and 46 to 78 years among males. During 2005–09, life
expectancy was lowest in Lesotho and again highest in Japan, ranging from 45 to 86 years among females and 45 to
80 years among males. For the US, estimates of net survival differed by up to 4% if background mortality was fully
controlled with state- and race-specific life tables, rather than with national race-specific life tables.
Conclusions: Background mortality varies worldwide. This emphasises the importance of using population-specific life
tables for geographic and international comparisons of net survival.
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Background
The CONCORD-2 study was designed to establish long-
term surveillance of cancer survival worldwide, by
central analysis of population-based cancer registry data.
Net survival from 10 common malignancies was esti-
mated from individual patient data submitted by 279
cancer registries in 67 countries [1].
Net survival of a cohort of cancer patients is estimated as
the probability of survival derived solely from the cancer-
specific hazard of death. It can be interpreted as the pro-
portion of cancer patients who survive up to a given time
after diagnosis (e.g. 5 years), after eliminating the impact of
other causes of death (background mortality). This is done
by separating the excess hazard of death due to cancer from
the background mortality. Background mortality often
differs widely between populations, and can even differ sub-
stantially within registry populations, for instance by race
[2], ethnic group [3] or socio-economic status [4].
Information on background mortality in a given popu-
lation is obtained from life tables, which are tables of
age- and sex-specific death rates or probabilities in a
given population at a given point in time. Net survival
will be more accurate if the estimates of background
mortality are as close as possible to each particular indi-
vidual’s “real” expected mortality from all causes. Previ-
ous international studies of cancer survival [5], including
the first CONCORD study [2, 6], have recommended
that life tables specific to the area in which cancer
patients live should be used, rather than national life
tables, which may not account for sub-national differ-
ences in mortality. Ideally, these life tables should be by
single calendar year, single year of age, sex, and race (or
ethnicity) or deprivation when the relevant data are avail-
able. Such life tables are, however, not generally available:
national statistical offices often only produce life tables for
the whole country or major geographic regions.
In this article, we outline the methods used to construct
life tables for the CONCORD-2 study, which is the largest
comparison of worldwide trends in population-based can-
cer survival to date. We document the wide variations in
life expectancy and age-specific mortality between and
within the populations covered by the 279 participating
cancer registries. We examine trends in life expectancy in
regions within continents, and even within countries. We
also investigate the importance of using regional vs.
national life tables in the estimation of net survival, by com-
paring estimates for four adult cancers (breast, colon, lung,
prostate) in 44 US registries, using either a US national,
race-specific life table [7] or the race- and state-specific life
tables that were constructed for the CONCORD-2 study.
Methods
All 279 cancer registries participating in the CONCORD-
2 study were invited to contribute data for patients
diagnosed during all or part of the calendar period 1995–
2009, with follow-up to 31 December 2009, or a later year.
To enable estimation of net survival for these patients,
registries were asked to provide data on background mor-
tality for each calendar year for which they submitted can-
cer data, from the first year of incidence to the last year of
follow-up. They were offered the option of supplying their
own life tables or providing death and population counts
from which we could construct the life tables required.
Some registries also supplied life table data for racial or
ethnic sub-populations within their territory: in all, we re-
ceived data for 327 populations. The Israel National
Cancer Registry and all 44 participating United States
(US) cancer registries submitted death and population
data from which to construct life tables by ethnicity
(Israel, national-level) or race (US, state-level). The New
Zealand Cancer Registry and the Penang Cancer Registry
(Malaysia) provided mortality rates by ethnicity at a na-
tional level. Both the Polish National Cancer Registry and
the Austrian Cancer Registry submitted mortality rates for
the sub-regions covered by their registries (voivodeships
for Poland, bundeslands for Austria). Neither registry
submitted data by ethnicity.
We classified the data we received into four categories
on the basis of their structure and quality: i) death and
population counts by single year of age; ii) death and
population counts by age group (typically five years); iii)
mortality rates by single year of age; and iv) mortality
rates by age group. A fifth category included registries
from which life table data were unavailable or deemed
unreliable. The methods used to construct life tables
were different for each of the five categories (Table 1).
Some registries did not provide life tables (or the corre-
sponding death and population counts) for each calendar
year covered by their cancer data. We constructed life ta-
bles for any intervening years by linear interpolation of the
age-specific death rates. If the calendar span of life tables
was shorter than the calendar span of the cancer incidence
and follow-up data, life tables for the earliest or latest avail-
able year were used for the missing years, i.e. without ex-
trapolation, so that we would have estimates of background
mortality for every year included in the cancer data.
Life tables from death and population counts (categories
i and ii)
In all, 172 (62%) of the participating registries provided
data on the numbers of deaths and the population size
(death and population counts) by age and sex (table 1). A
flexible multivariable model (flexible Poisson model) [8]
was used to derive the required age- and sex-specific mor-
tality rates. This method was chosen because it was
recently recommended for the estimation of smoothed
age-specific mortality rates for small populations [8]. This
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approach also allowed for the modelling of mortality rates
by race or ethnicity, where the data were available.
The death counts were modelled separately for each
sex and calendar year, within the generalised linear
model framework, using a Poisson error and log link.
Person-years at risk were used as the offset:
log dxð Þ ¼ β0 þ f xð Þ þ log pyrsxð Þ
where x denotes age in years, dx denotes the age-specific
death count, β0 denotes the coefficient at baseline (i.e.
the log of the mortality rate at the reference age), f(x)
denotes a restricted cubic spline function on age, and
pyrsx denotes the age-specific person-years at risk.
The model was implemented using the Stata com-
mand mvrs (multivariable regression splines) [9] in Stata
13. Splines are made up of piecewise polynomial func-
tions joined at locations called knots. The process we
used to select the knot locations is summarised in
Additional file 1 and in detail elsewhere [8]. We used
the flexible Poisson model with a continuous interaction
between race/ethnicity and age to construct race/ethni-
city-specific life tables for the Israel National Cancer
Registry (ethnicity) and the 44 US states (race). Further
details are provided in Additional file 2.
We used three calendar years of death and population
counts around a central year, so that the resulting life tables
would not be as susceptible to year - on - year fluctuations.
Life tables from mortality rates (categories iii and iv)
We obtained age-specific mortality rates from 83 (30%)
of the participating registries (Table 1). Of these, 73
(88%) provided mortality rates by single year of age
(complete life tables) and 10 (12%) provided rates by
five-year age group (abridged life tables). Of those
registries that submitted complete life tables, 56 (77%)
provided smoothed versions for each calendar year sub-
mitted (where the raw, age-specific mortality rates had
been modelled up to age 99 years to remove any random
fluctuations by age) and 17 (23%) did not.
Where the mortality rates we received had not been
smoothed, we used the Ewbank relational method [10]
to derive a smoothed mortality profile for the given
population. The Ewbank method is an extension of the
Brass relational method [11]. The Brass method involves
plotting the linear relationship between the logits of two
survivorship functions, one from a standard life table
and the other from observed data. Plotting this linear re-
lationship provides information on two parameters, one
for the level of mortality in the model (a) and another
for the slope of the observed survivorship curve relative
to the standard curve, i.e. the relation between young
and old age mortality in the observed data relative to the
standard (β). These two parameters are then used to de-
termine the shape of a smoothed survivorship function
for the observed data. The Ewbank method includes two
additional parameters: one for childhood mortality (κ)
and another for mortality at older ages (λ). The param-
eter for childhood mortality applies before the median
age at death in the population. The parameter for mor-
tality at older ages applies after the median age at death.
If mortality rates were available by single year of age
up to 99 years, we used all four parameters (level of
mortality, relation between young and old age mortality,
childhood mortality, older-age mortality). In many popu-
lations, the median age at death was close to 80 years of
age, or higher. For abridged life tables, in which the
highest age group is typically for ages 85 years and
above, this meant that data to estimate values for the
older-age mortality parameter (which only applies after
Table 1 Methods used to construct the CONCORD-2 life tables, by type of data obtained
Data category Method No. of registries
Death and population counts 172
i) By single year of age Multivariable flexible model 72
ii) By age group Multivariable flexible model 100
Mortality rates 83
iii) By single year of age 73
Smoothed Calendar year interpolation if necessary 56
Unsmoothed Ewbank relational model with four parameters 17
iv) By age group Ewbank relational model with three parameters 10
No reliable life table data available from registry 24
Abridged life table available from the
UN Population Division (UNPD)
Abridged UNPD life tables interpolated using
Elandt-Johnson method
23
Abridged life table not available from
UNPD (Gibraltar only)
Smoothed England life table used 1
Total: 279
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the median age at death) were often available for only
one or two age groups. This has previously been found
to cause instability in the estimated older-age mortality
parameter, leading to unreliable estimates of older-age
mortality [12]. For abridged mortality rates, we therefore
used only three parameters and constrained the param-
eter for older-age mortality to be a factor of the param-
eter for the level of mortality [10].
Registries for which no reliable data were available
(category v)
We were unable to obtain reliable life table data from 24
(8%) registries (Table 1). For 23 of these registries, we
used country-level life tables by age group (abridged) for
calendar periods 1995–2000, 2000–2005 and 2005–2010
obtained from the UN Population Division (UNPD) [13].
We centred these on years 1997, 2002 and 2007 and
smoothed the abridged values using the Elandt-Johnson
method [14]. The Elandt-Johnson method has been rec-
ommended for deriving single-year-of-age life tables
from abridged ones [15]. As above, we produced life ta-
bles for individual calendar years by age-specific linear
interpolation between the life tables for each of the three
calendar periods. For one of these registries, Gibraltar,
no life table data were available from the UNPD [13],
WHO [16], Global Burden of Disease Study [17] or the
Human Mortality Database [18], so we used the life table
we constructed for England.
Evaluation and comparison of derived life tables
Life expectancy at birth is a summary measure of age-
specific mortality. We calculated life expectancy at birth,
the infant mortality rate (probability of dying between
birth and exact age 1), childhood mortality rate (probabil-
ity of dying between birth and exact age 5), and the prob-
abilities of dying between exact ages 15 and 60, 60 and 85,
and 85 and 99 years from each of the derived life tables.
Life expectancies at birth and the probabilities of death
were summarised in a standardised report for each
cancer registry (see example in Additional file 3). The
reports included plots of the smoothed mortality curves
on both logarithmic and arithmetic scales.
Performance of the flexible Poisson model was also
evaluated from plots of the deviance residuals at each
age. Deviance residuals are a measure of how closely the
modelled values fit the observed data. The residuals
should be approximately normally distributed, with a
constant range, if the model fits the data well [19]. We
deemed the model to be performing well if the standar-
dised deviance residuals were in the range −2 to +2.
Results
In total, 6,514 life tables were constructed as part of the
CONCORD-2 study: of these, 6,392 life tables were con-
structed for 223 (80%) registries with the flexible Poisson
model, the Ewbank method or the Elandt-Johnson
method. A further 35 registries (12.5%) provided smoothed
life tables that did not cover all calendar years; for these
registries, we constructed 122 life tables by linear
interpolation. We received smoothed, complete, life tables
for all calendar years from 21 registries (7.5%). No modifi-
cations were required for these life tables.
The type of data received varied by continent (Table 2).
With the exception of Mauritius, no African registries
provided reliable life table data, whereas the great major-
ity of registries from the Americas (North, Central and
South) provided death and population counts.
Life expectancy at birth was higher among females
than males in all populations except Mali (Bamako
Cancer Registry), throughout 1995–1999, 2000–2004
and 2005–2009 (Additional file 4).
Global variation in life expectancy at birth was very
wide (Table 3; Figs. 1 and 2; Additional file 4). Life ex-
pectancy was highest in Japan for males and females
throughout the 15-year period 1995–2009. It was lowest
in Nigeria during 1995–1999 (47 years for females,
46 years for males) and Lesotho during 2000–2004 and
2005–2009 (e.g. 45 years for females, 45 years for males
Table 2 Type of life table data obtained from each cancer registry: number of registries, by continent
Type of life table data
Mortality rates Death and population counts No data Total
By single year of age By age group By single year of age By age group
Continent No. (%) No. (%) No. (%) No. (%) No. (%) No.
Africa – – – – 1 (10) – – 9 (90) 10
America (Central and South) 1 (4) – – 4 (15) 19 (70) 3 (11) 27
America (North) – – – – 9 (16) 48 (84) – – 57
Asia 3 (6) 6 (12) 11 (22) 19 (38) 11 (22) 50
Europe 63 (49) 3 (2) 47 (37) 14 (11) 1 (1) 128
Oceania 6 (86) 1 (14) – – – – – – 7
Total 73 (26) 10 (4) 72 (26) 100 (36) 24 (9) 279
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Fig. 1 Life expectancy at birth (years), by sex: earliest and latest years of life table data. Each data point represents a single population, either for a
registry territory, or for a racial/ethnic sub-population within a given territory. This figure shows the change in life expectancy at birth, by sex,
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327 populations. The diagonal represents ‘no change’ between the first and last years: data points above the diagonal denote an increase in life
expectancy for that population
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in 2005–2009; Table 3, Additional file 4). During 1995–
1999, life expectancy at birth ranged from 47 to 84 years
among females and 46 to 78 years among males. During
2005–2009, it ranged from 45 to 86 years among females
and 45 to 80 years among males. The largest range
within any continent was observed in Africa, where life
expectancy in 2005–2009 varied by as much as 30 years
between populations (from 45 to 77 years among fe-
males, and 45 to 72 years among males). If North Africa
is considered separately from East, West and South
Africa, however, the ranges within these two regions are
narrow. The narrowest range was observed in North
America during 1995–1999 (6 years for females, 4 years
for males) and Oceania in 2005–2009 (9 years for
females, 10 years for males).
Striking changes occurred in life expectancy in some
countries between the earliest and latest calendar years for
which we obtained life table data (Fig. 1). Among males,
life expectancy fell by up to six years in South Africa and
Lesotho. Among females, it fell by nine and seven years,
respectively. By contrast, life expectancy rose by six years
or more in Estonia, Latvia (males only), South Korea, São
Paulo (Brazil, males only), Changle (China, females only),
Haining (China), and East Germany (males only).
These variations and trends in life expectancy at birth
summarise the underlying patterns and trends in age-
specific mortality, which also varied very widely (Table 3;
Figs. 3, 4 and 5; Additional file 4). Worldwide, the great-
est range in the probability of death among adults was
seen in the age range 60 to 85 years, both during 1995–
1999 (37.9% to 93.7% among females; 55.9% to 94.3%
among males) and during 2005–2009 (31.5% to 93.5%
among females; 51.4% to 93.9% among males).
Where we obtained background mortality data by race
or ethnic group, the majority group (whites in the United
States, Jews in Israel, Non-Maoris in New Zealand) tended
to have higher life expectancy at birth than the other
subgroup(s). Malaysia (Penang Cancer Registry) was the
exception, where life expectancy among the Chinese
(23% of the population) was higher than among the major-
ity Malay (50%) population [20] (Fig. 6; Additional file 4).
Correspondingly, there were clear disparities in age-
specific mortality, but the rates tended to converge
among the elderly.
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For some states in the US, the population of blacks is
so small that death counts were not available for several
age groups. We were therefore unable to construct ro-
bust life tables for blacks in Hawaii, New Hampshire,
Montana, Idaho or Wyoming, even with the flexible
Poisson model. For Utah and Alaska, the black life tables
were also based on small counts, but data were available
for enough age groups for us to construct life tables for
use in survival analyses.
Impact of using state- and race-specific life tables
We compared five-year net survival estimates for the 44
participating US registries for patients diagnosed during
2005–2009, obtained using state- and race-specific life
tables that we had constructed using the flexible Poisson
model, with the corresponding survival estimates derived
with the national, race-specific life tables obtained from
the National Center for Health Statistics (NCHS) [21].
For this comparison, we chose four cancers with very
different prognosis: breast and prostate (high), colon
(medium) and lung (low).
Absolute differences between the two sets of survival
estimates were greatest for states where life expectancy
at birth differed most from the national average, and for
cancers with a better prognosis. They were smallest for
states where life expectancy at birth differed least from
the national average, and for cancers with a poor prog-
nosis, where the majority of deaths were excess deaths.
Differences were largest for men with prostate cancer,
and for women with breast cancer, and smallest for lung
cancer in both sexes (Table 4). The greatest difference
was 3.6% for prostate cancer in Mississippi.
Discussion
In order to establish worldwide surveillance of population-
based cancer survival trends in the CONCORD-2 study [1],
we needed to obtain or construct life tables of background
mortality by age, sex and calendar year that were as specific
as possible for each registry population or sub-population.
This was particularly important in light of the tremen-
dous intra-continental and even sub-national variations in
background mortality. The UN Population Division, the
World Health Organisation and the Global Burden of
Disease study regularly produce life tables for countries
worldwide [13, 16, 17, 22], but they are for countries, ra-
ther than sub-regions or ethnic/racial groups, and they
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period denote the number of registries contributing life table data for that calendar period. Each dot on the graph represents a registry
population or sub-population
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may not accurately reflect the background mortality in the
specific population(s) covered by a cancer registry.
We were obliged to use several methods to construct
the life tables, because of the different types of data avail-
able from the registries (complete or abridged death and
population counts; complete or abridged mortality rates;
no reliable data). These methods involved different as-
sumptions about the shape of age-mortality patterns and
the rate of increase of mortality at older ages. The differ-
ent assumptions made in the construction of the life tables
may have had an impact on the subsequent estimates of
net survival, and this warrants further investigation.
We recommend using the multivariable flexible Poisson
model to construct life tables for future international com-
parisons of population-based cancer survival. We found
that this method performed well, even for small popula-
tions. It does not rely on an external standard population
or a pre-defined set of coefficients, and therefore does
not make strong assumptions about the age-pattern
of mortality. It was also recently found to perform
better than the Elandt-Johnson method and a flexible
relational method (based on the Ewbank approach)
for small populations [8].
Life expectancy at birth varied by more than 30 years
among the 327 populations examined in the 279 registries.
In Canada alone, during 2005–2009, life expectancy
differed by 10 years between residents of Nunavut (fe-
males 73.4 years; males 68.3 years) and British Columbia
(females 83.4 years; males 78.9 years). These differences
are probably explained by the very different demographic
profiles of these two provinces: aboriginal people made up
86% of the population of Nunavut in 2011 [23].
In most populations, life expectancy increased during
1995–2009, but in Lesotho and South Africa it fell by as
much as 6 years, most probably because of the HIV/
AIDS epidemic emerging in those countries during the
1990s [24, 25].
We constructed ethnic or race-specific life tables for
Israel, Malaysia (Penang Cancer Registry), New Zealand
and the US. These life tables showed marked differences
in background mortality between the ethnic and racial
sub-populations in each country. In 5 of the 44 partici-
pating US states (Hawaii, New Hampshire, Montana,
Idaho, Wyoming), it was not possible to construct suffi-
ciently robust life tables for blacks. However, we were
able to use race- or ethnic-specific life tables to estimate
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period denote the number of registries contributing life table data for that calendar period. Each dot on the graph represents a registry
population or sub-population
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net survival in 39 of the 44 US registries, and for Israel,
Penang (Malaysia) and New Zealand, controlling for
background mortality by age and sex separately within
each race or ethnicity. This was a strength of the
CONCORD-2 study.
Examination of the impact of using race-specific life ta-
bles for each US state on estimates of net survival showed
that age-standardised estimates differed by up to 3.6%,
when compared with estimates obtained with the national
race-specific life tables that have been used in the past.
The differences were more marked for cancers with better
prognosis. This is in line with previous findings [2, 26].
The largest difference observed was in the estimate of
age-standardised five-year net survival for prostate cancer
in Mississippi, which was 3.6% higher when derived with
state- and race-specific life tables than when using na-
tional life tables. The explanation is that background mor-
tality among adults in Mississippi is considerably higher
Fig. 6 Life expectancy at birth (years) by race/ethnicity and sex: 2005–2009. Data are presented for Israel, Malaysia, New Zealand and 38* states of
the United States. Hollow diamonds denote the majority ethnic group in each population. * Six metropolitan SEER registries were also included
in the CONCORD-2 study, but the life tables used were those of the parent state (see text)
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than the US national average, for both blacks and whites.
National life tables therefore under-estimate background
mortality in Mississippi, leading us to over-estimate excess
mortality and subsequently underestimate net survival. Of
note, we did not investigate age-, sex- or race-specific
differences in net survival estimated with the alternative
life tables. Differences in net survival from those obtained
with national life tables will be larger in some of the
groups defined by age and race and, for other cancers, sex.
This is a further reason for using the most specific life
tables that can be obtained.
Stroup et al. [26] recently examined the differences be-
tween estimates of relative survival by age, sex and race
for 17 SEER registries, obtained either with state- and
race-specific life tables or with national, race-specific life
tables. The differences were greatest for patients aged
85 years or over, and differed in both direction and mag-
nitude by race and sex. They deemed the NCHS state-
and race-specific life tables unreliable above age 85 and
recommended against using them to estimate relative
survival for patients aged 85 and older. We have com-
pared the probabilities of dying between ages 85 and
99 years for each state, race and sex derived from the
CONCORD-2 life tables with those derived from the
national, race-specific life tables available from NCHS.
Estimates of the probability of dying between ages 85
and 99 were higher for black males and females, and to
a lesser extent for white males, when derived from the
CONCORD-2 state- and race-specific life tables than
when derived with the national life tables. For white
females, the estimates derived from the CONCORD-2
life tables were fairly evenly distributed around the
corresponding national estimates.
We opted to use life tables that were specific to each
registry or sub-population, wherever possible, in order
to reflect as closely as possible the background mortality
that an individual cancer patient would be expected to
experience. This is critical when estimating net survival.
Accurate life tables allow us to estimate the net survival
of cancer patients within each population, rather than an
approximation obtained with a less specific life table.
Table 4 Absolute differences in five-year net survival estimates
obtained using national versus state-specific, race-specific life tables
Absolute difference (%) in five-year net survival
estimates
Colon Lung Breast Prostate
Alabama 1.81 0.37 2.12 3.30
Alaska –0.77 –0.10 –0.37 –1.10
California –0.82 –0.17 –0.80 –1.16
Greater Bay Area –0.84 –0.19 –0.87 –0.43
Greater California –0.86 –0.15 –0.83 –1.37
Los Angeles –0.73 –0.18 –0.65 –1.28
Colorado –0.62 –0.18 –0.55 –0.80
Connecticut –1.12 –0.33 –1.28 –1.24
Delaware –0.07 –0.03 0.14 –0.17
Florida –1.49 –0.45 –1.71 –0.72
Georgia 1.12 0.23 1.32 2.11
Atlanta 1.12 0.26 1.30 1.04
Hawaii –2.27 –0.45 –3.09 –1.61
Idaho –0.15 –0.09 –0.01 –0.45
Iowa –0.21 –0.07 –0.50 –0.14
Kentucky 1.82 0.39 2.07 3.32
Louisiana 1.33 0.28 1.58 2.33
Maryland –0.18 –0.03 –0.15 –0.20
Massachusetts –0.42 –0.15 –0.60 –0.22
Michigan 0.38 0.08 0.42 0.57
Detroit 0.43 0.09 0.47 0.54
Mississippi 1.63 0.42 2.09 3.56
Montana –0.19 –0.07 0.01 –0.59
Nebraska –0.18 –0.08 –0.26 –0.31
New Hampshire –0.24 –0.08 –0.26 0.04
New Jersey –0.33 –0.11 –0.48 –0.24
New Mexico –0.47 –0.09 –0.38 –1.12
New York –0.85 –0.23 –1.02 –1.01
North Carolina 0.61 0.13 0.62 1.25
Ohio 0.82 0.19 0.93 1.19
Oklahoma 1.75 0.38 2.32 2.85
Oregon –0.07 –0.03 0.05 –0.29
Pennsylvania 0.33 0.07 0.21 0.63
Rhode Island –0.18 –0.07 –0.51 0.07
South Carolina 0.70 0.17 0.72 1.49
Tennessee 1.53 0.38 1.68 2.55
Texas 0.43 0.10 0.60 0.59
Utah –0.67 –0.17 –0.17 –0.43
Virginia 0.24 0.02 0.28 0.42
Washington –0.38 –0.08 –0.22 –0.49
Seattle –0.37 –0.08 –0.20 –0.30
Table 4 Absolute differences in five-year net survival estimates
obtained using national versus state-specific, race-specific life tables
(Continued)
West Virginia 2.18 0.44 2.57 3.51
Wisconsin –0.25 –0.10 –0.51 –0.24
Wyoming 0.10 0.02 0.54 –0.05
Absolute difference in the five-year net survival (%) estimate for all patients
diagnosed during 2005–2009 in each US registry obtained with (a) national,
race-specific life tables and (b) state- and race-specific life tables. A negative
value indicates that the estimate obtained with state- and race-specific life
tables was lower than the estimate obtained with national, race-specific life
tables. Absolute differences greater than 3% are shown in bold, along with the
associated registry name
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This is particularly important for worldwide compari-
sons of cancer survival.
This was the first opportunity for us to use our flexible
Poisson model [8] to construct life tables for such a large
and disparate set of populations. The model generally
performed well, even when the death counts were
sparse. In some US states (California, New York, Alaska
and Colorado), however, where the races classified as
“Other” (American Indian/Alaska Native, Asian/Pacific
Islander) made up a large proportion of the total popula-
tion, the fit of the life table for blacks was not ideal, par-
ticularly at the oldest ages. This is probably because the
interaction between race and age was modelled as a con-
tinuous variable, meaning that greater weight was given
to the shape of the mortality function for “other” races
at older ages than to that for blacks. This may have con-
tributed to some over-estimation of background mortal-
ity among elderly blacks. We determined that inclusion
of an interaction between race and age in the model as
dummy variables (see Additional file 5) provided a better
fit of the race-specific mortality rates to the underlying
data, and we produced a new set of life tables for the US
registries with this approach. We have also explored the
inclusion of calendar year as a covariable: we believe this
could facilitate construction of more robust life tables
for future comparisons of cancer survival.
In some circumstances, we were limited by the availabil-
ity of data, in others by data quality. For some popula-
tions, raw infant and child mortality rates were very low,
suggesting some undercounting of infant deaths. In some
populations, (sometimes the same populations), mortality
rates at very old ages were remarkably high, perhaps indi-
cating inaccurate reporting of the age at death (too high)
or undercounting of older-age populations. Where pos-
sible, we compared our estimates of life expectancy with
those available from the national statistical authority for
the country or region covered by the cancer registry.
These were generally very comparable. The quality and
completeness of civil and vital registration statistics varies
substantially around the world, however, and only about
one-third of all deaths are actually registered. To improve
the robustness of research on demographic trends it is
critical to push for the improvement of vital statistics
data worldwide [27, 28]. This would benefit inter-
national public health research, including international
comparisons of cancer survival, by enabling wider par-
ticipation, particularly in low- and middle-income
countries.
Conclusions
The methods by which life tables are constructed for the
estimation of cancer survival depend on the nature and
detail of the available data on death and population
counts, or mortality rates.
To our knowledge, this study represents the first time
such a large number of national and sub-national life ta-
bles have been constructed on a global scale. We found
wide variations and major changes over time in life
expectancy at birth, and in patterns of mortality by age,
between 327 populations in the territory of 279 participat-
ing registries. This highlights the importance of using life
tables that are as specific as possible to the populations or
sub-populations for which comparisons of net survival are
required, in order to control adequately for variations in
background mortality between populations and over time.
The life tables used by the CONCORD programme
are all available online. They can be downloaded from
the Cancer Survival Group website [29].
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